Glade Guides
Search

Cipla

Sector: Healthcare | Industry: Drugs & Pharma
R 640.45 0.70 | 0.11% 1.32% 35.48 51,548.22
NSE Price: Oct 17, 15:59 Change R | % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 17, 15:59 640.45 0.70 0.11% 644.90 639.75 1,280,980 637.00 - 646.00
BSE Oct 17, 2018 640.15 0.15 0.02% 644.00 640.00 247,221 637.35 - 646.25
Exchange & Time Last Price Day Change Open Prev Close Volume 1-Day Range
6M Average Volume: 2,718,156 P/B: 3.53 NSE Code: CIPLA
52-Week Range: R 507.20 - 678.45 Dividend Yield: 0.47% BSE Code: 500087
TTM EPS: R 18.04 Book Value: R 181.43 Face Value: R 2
Price Graph
  • Sun Pharmaceutical Inds. (NSE)
  • NIFTY 100


Please wait while we are fetching data...
Get the best stock ideas
Want to create meaningful wealth through stock investing?
Performance
YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Cipla 5.25 -3.68 0.47 1.32 -1.95 9.07 12.48
NIFTY 50 -0.74 -8.13 -5.04 2.14 8.25 11.57 13.01
NIFTY Pharma 0.69 -7.79 8.52 -0.56 -9.79 5.12 14.20
Company's return has been calculated on basis of NSE's price.
As on Oct 17, 2018
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
1-Year 3-Years 5-Years
Growth
Revenue 5.29 10.13 12.85
Net Profit 36.16 4.21 -1.76
EPS 40.05 6.01 -1.86
Book Value 13.39 9.67 9.41
Average
Operating Margin 18.55 17.99 19.61
Net Margin 9.15 8.80 10.17
Return on Networth 10.65 10.66 11.79
Return on Investment 10.20 10.57 13.22
Interim Growth Ratios (%)
QoQ YoY YTD
Quarterly
Revenue 6.52 11.74 6.52
Operating Profit 50.19 12.36 50.19
Net Profit 191.59 4.91 191.59
EPS 152.61 10.29 152.61
TTM
Revenue 2.72 7.78 2.72
Operating Profit 3.10 14.54 3.10
Net Profit 1.47 28.32 1.47
EPS 2.98 34.91 2.98
Peer Comparison
Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Cipla 51,548.22 15,633.19 1,440.25 9.00 10.65 3.53 35.48
Aurobindo Pharma 44,309.26 17,071.36 2,357.97 13.71 22.99 3.65 18.77
Sun Pharmaceutical Inds. 142,387.92 27,504.84 4,064.54 14.32 7.05 3.63 39.90
Insider Trades
Date Person Buy / Sell Transaction
Type
No of Shares Price
(R)
Value
(R Lakhs)
Oct 04, 2018 Akshay Kejriwal Sell Market 2,300 638.40 14.68
Oct 04, 2018 Ranjana Pathak Sell Market 11,000 638.40 70.22
Sep 10, 2018 Anita Desai Buy ESOS 7,391 668.05 49.38
Sep 10, 2018 Preeti Raut Buy ESOS 2,639 668.05 17.63
Aug 22, 2018 Nikhil Chopra Sell Market 8,500 650.25 55.27
Fund Houses invested in the stock
Fund Sep-18 Jun-18 Mar-18 Dec-17 Sep-17
ICICI Prudential Mutual Fund 3.635 3.967 3.959 3.660 3.930
HDFC Mutual Fund 2.713 2.857 2.889 2.459 2.232
SBI Mutual Fund 1.213 0.930 0.725 0.677 0.778
UTI Mutual Fund 0.978 0.902 0.702 0.558 0.412
Reliance Mutual Fund 0.745 1.040 1.369 1.422 1.280
Aditya Birla Sun Life Mutual Fund 0.557 0.557 0.011 0.014 0.047
Invesco Mutual Fund 0.288 0.213 0.103 0.022 0.004
Mirae Asset Mutual Fund 0.276 0.200 - - -
L&T Mutual Fund 0.241 0.181 - - -
Quantum Mutual Fund 0.067 0.067 0.067 0.065 0.060
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Cipla Ltd.

Address: Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai, Maharashtra - 400013 | Phone: 022-24826000 / 022-24826951 | Fax: 022-24826893

Email: cosecretary@cipla.com

Website: cipla.com

Registrar & Transfer Agent: Karvy Computershare Pvt Ltd

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: einward.ris@karvy.comWebsite: karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: einward.ris@karvy.com

Website: karvy.com

comments powered by Disqus
Essential checks
Altman Z-Score
6.02
Piotroski F-Score
8
Modified C-Score
2
5-Years Price to Earnings
35.48
5-Years Price to Book
3.53
Earnings Yield
EBIT / Enterprise value
3.46%
PEG
Price / Earnings to growth ratio
-17.70
Related Stocks
Current Price Chng %
Alkem Laboratories R1,981.25 +0.36%
Aurobindo Pharma R756.30 -2.48%
Biocon R636.55 +1.22%
Cadila Healthcare R377.55 -0.66%
Divi's Laboratories R1,301.20 -0.49%
Dr. Reddy's Lab R2,565.00 -0.33%
Lupin R896.65 +0.02%
Piramal Enterprises R2,098.75 -9.94%
Sun Pharmaceutical Inds. R593.45 -1.53%
Torrent Pharmaceuticals R1,560.85 -4.02%
As on Oct 17, 15:59